mild-persistent asthma
Jump to navigation
Jump to search
Clinical manifestations
- beta-gonist use > 2 days/week, but < daily
- asthma-related night-time wakenings > 2 nights/month, but < 1 night/week
Diagnostic procedures
Management
- inhaled glucocorticoid
- budesonide MDI BID or equivalent
- more symptom-free days
- oral leukotriene receptor antagonist
- zafirlukast
- may be of little value
- inhaled beta-adrenergic agonist PRN
More general terms
References
- ↑ Journal Watch 25(10):84, 2005 Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fagan JK, Fish JE, Ford JG, Kraft M, Lemanske RF Jr, Leone FT, Martin RJ, Mauger EA, Pesola GR, Peters SP, Rollings NJ, Szefler SJ, Wechsler ME, Israel E; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005 Apr 14;352(15):1519-28. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/15829533
- ↑ <Internet> http://www.nhlbi.nih.gov/health/prof/lung/asthma/practgde/practgde.pdf